Advanced search
Publication Cover
Leukemia & Lymphoma Volume 46, 2005 - Issue 8
Submit an article Journal homepage
81
Views
27
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of hairy cell leukemia variant with rituximab

S Narat Department of Haematology, Royal Free Hospital, Hampstead, London, UK; Department of Haematology, Royal Free Hospital, Hampstead, London, UK
,
J Gandla Department of Haematology, Royal Free Hospital, Hampstead, London, UK; Department of Haematology, Royal Free Hospital, Hampstead, London, UK
,
A Dogan Department of Haematology, Royal Free Hospital, Hampstead, London, UK; Department of Histopathology, Royal Free Hospital, Hampstead, London, UK
&
A Mehta Department of Haematology, Royal Free Hospital, Hampstead, London, UK; Department of Haematology, Royal Free Hospital, Hampstead, London, UKCorrespondence[email protected]
Pages 1229-1232 | Received 15 Feb 2005, Published online: 03 Aug 2009

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Qiuying Liu, Nicholas Harris, Narendranath Epperla & Leslie A Andritsos. (2021) Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant. OncoTargets and Therapy 14, pages 1797-1805.
Read now
Estella Matutes. (2021) Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?. Expert Review of Hematology 14:4, pages 355-363.
Read now
Montserrat López-Rubio & Jose Antonio Garcia-Marco. (2015) Current and emerging treatment options for hairy cell leukemia. OncoTargets and Therapy 8, pages 2147-2156.
Read now
Faisal Basheer, David M Bloxham, Mike A Scott & George A Follows. (2014) Hairy cell leukemia – immunotargets and therapies. ImmunoTargets and Therapy 3, pages 107-120.
Read now
Tadeusz Robak. (2011) Management of hairy cell leukemia variant. Leukemia & Lymphoma 52:sup2, pages 53-56.
Read now
Farhad Ravandi. (2011) Chemo-immunotherapy for hairy cell leukemia. Leukemia & Lymphoma 52:sup2, pages 72-74.
Read now
Tadeusz Robak. (2008) Emerging drugs for rarer chronic lymphoid leukemias. Expert Opinion on Emerging Drugs 13:1, pages 95-118.
Read now

Articles from other publishers (20)

Julie Tran, Charles Gaulin & Martin S. Tallman. (2022) Advances in the Treatment of Hairy Cell Leukemia Variant. Current Treatment Options in Oncology 23:1, pages 99-116.
Crossref
Martina Sollini, Francesco Bartoli, Sara Galimberti, Roberto Boni & Paola A. Erba. 2020. Nuclear Oncology. Nuclear Oncology 1 52 .
Martina Sollini, Francesco Bartoli, Sara Galimberti, Roberto Boni & Paola A. Erba. 2022. Nuclear Oncology. Nuclear Oncology 1329 1380 .
Matthew Cross & Claire Dearden. (2020) Hairy Cell Leukaemia. Current Oncology Reports 22:5.
Crossref
Paul Letendre & Donald Doll. (2018) Novel therapeutics in the treatment of hairy cell leukemia variant. Leukemia Research 75, pages 58-60.
Crossref
Andrea Visentin, Silvia Imbergamo, Federica Frezzato, Marco Pizzi, Roberta Bertorelle, Edoardo Scomazzon, Tamara Berno, Marcello Riva, Elisa Piva, Monica Facco, Francesco Piazza, Gianpietro Semenzato & Livio Trentin. (2017) Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases. Oncotarget 8:66, pages 110727-110731.
Crossref
Martina Sollini, Sara Galimberti, Roberto Boni & Paola Anna Erba. 2017. Nuclear Oncology. Nuclear Oncology 1157 1195 .
Martina Sollini, Sara Galimberti, Roberto Boni & Paola Anna Erba. 2016. Nuclear Oncology. Nuclear Oncology 1 39 .
Estella Matutes, Alejandra Martínez-Trillos & Elias Campo. (2015) Hairy cell leukaemia-variant: Disease features and treatment. Best Practice & Research Clinical Haematology 28:4, pages 253-263.
Crossref
T. Robak, E. Matutes, D. Catovsky, P.L. Zinzani & C. Buske. (2015) Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 26, pages v100-v107.
Crossref
Robert J. Kreitman, Wyndham Wilson, Katherine R. Calvo, Evgeny Arons, Laura Roth, Jeffrey Sapolsky, Hong Zhou, Mark Raffeld & Maryalice Stetler-Stevenson. (2013) Cladribine with Immediate Rituximab for the Treatment of Patients with Variant Hairy Cell Leukemia. Clinical Cancer Research 19:24, pages 6873-6881.
Crossref
Tetsumi Yoshida, Keichiro Mihara, Sayaka Sugihara, Koji Arihiro, Tatsuji Mino, Naomi Sasaki & Yoshihiro Takihara. (2012) Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant. Annals of Hematology 92:5, pages 711-713.
Crossref
Haipeng Shao, Katherine R. Calvo, Marlene Grönborg, Prashant R. Tembhare, Robert J. Kreitman, Maryalice Stetler-Stevenson & Constance M. Yuan. (2013) Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria. Leukemia Research 37:4, pages 401-409.
Crossref
Gail Jones, Nilima Parry-Jones, Bridget Wilkins, Monica Else & Daniel Catovsky. (2012) Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*. British Journal of Haematology 156:2, pages 186-195.
Crossref
George Kanellis, Luis Garcia-Alonso, Francisca I. Camacho, Juan Fernando Garcia, Manuela Mollejo, Santiago Montes-Moreno, Jose A. Garcia-Vela & Miguel A. Piris. (2010) Hairy cell leukemia variant. Journal of Hematopathology 4:1, pages 13-16.
Crossref
Tadeusz Robak. (2011) Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment. Cancer Treatment Reviews 37:1, pages 3-10.
Crossref
Evgeny Arons, Tara Suntum, Maryalice Stetler-Stevenson & Robert J. Kreitman. (2009) VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood 114:21, pages 4687-4695.
Crossref
Henry Y. Dong, James Weisberger, Zach Liu & Sorina Tugulea. (2009) Immunophenotypic Analysis of CD103+ B-Lymphoproliferative Disorders. American Journal of Clinical Pathology 131:4, pages 586-595.
Crossref
Tadeusz Robak. (2006) Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treatment Reviews 32:5, pages 365-376.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:3-4, pages 136-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.